Optimized AAV to express the unfolded protein response transcription factor XBP1s ameliorates Alzheimer's disease features in mouse models
Diaz, M. L.; Tamburini, G.; Arriagada, D.; Poblete, N.; Ardiles, A. O.; Neira, D.; Sepulveda, D.; Martinez, G.; Gozalvo, R.; Arcos, J.; Sepulveda-Quinenao, C.; Henckaerts, E.; Ferreira, S. T.; Palacios, A. G.; Hetz, C.
Show abstract
Proteostasis impairment at the level of the endoplasmic reticulum (ER) is a salient feature of Alzheimers disease (AD). The unfolded protein response (UPR) is the main pathway to cope with ER stress, where the expression of the transcription factor X-Box binding protein 1 (XBP1) is central to establish repair programs. To artificially enforce the adaptive capacity of the UPR in the AD brain, we recently reported the protective effects of overexpressing active XBP1 in the brain using adeno-associated vectors (AAVs) of AD mice, in addition to aged animals. Here we have generated a next generation vector suitable for clinical testing by (i) expressing codon-optimized human XBP1s without artificial tags, (ii) the use of the synapsin promoter to restrict expression to neurons, and (iii) incorporating a novel variant of AAV2 (AAV-TT) with greater biodistribution (here termed Proteostaser-1). Treatment of 5xFAD mice with Proteostaser-1 improved spatial learning and synaptic plasticity, and reduced the deposition of amyloid plaques in the brain. Proteostaser-1 administration also improved cognition in a model of sporadic AD based on the intracerebral injection of amyloid {beta} oligomers. Our results further support the therapeutic potential of the UPR as a strategy to ameliorate AD features and sustain synaptic function.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Retromer repletion with AAV9-VPS35 restores endosomal function in the mouse hippocampus 97%
- TOMM40 suppression promotes neuronal cholesterol imbalance and molecular and behavioral phenotypes of Alzheimer's disease 93%
- Impact of early locus coeruleus lesions in the TgF344 Alzheimer's disease rat model 93%
Similar papers in this journal
- The unfolded protein response transcription factor XBP1s ameliorates Alzheimer`s disease by improving synaptic function and proteostasis 94%
- APOE2 gene therapy reduces amyloid deposition, and improves markers of neuroinflammation and neurodegeneration in a mouse model of Alzheimer disease 92%
- Treatment of Huntington's disease with a pan-HTT-targeting CRISPR nuclease 92%
Similar papers in this journal
- A Compound Enhancing Lysosomal Function Reduces Tau Pathology, Microglial Reactivity and Rescues Working Memory in 3xTg AD Mice 95%
- Progression of fiber bundle damage in amnestic Alzheimer's disease and LATE: a 2-year fixel-based study 93%
- Inter- and intra-chromosomal modulators of the APOE ε2 and ε4 effects on the Alzheimer’s disease risk 92%
Similar papers in this journal
- Lactate treatment improves brain biochemistry and cognitive function in transgenic Alzheimer's and wild-type mice 94%
- Tauopathy in the APPswe/PS1ΔE9 mouse model of familial Alzheimer’s disease 94%
- Improvement of glymphatic-lymphatic drainage of beta-amyloid by focused ultrasound in Alzheimer's disease model 94%
Similar papers in this journal
- Gene-Based Analysis in HRC Imputed Genome Wide Association Data Identifies Three Novel Genes For Alzheimer’s Disease 93%
- Analysis of modular gene co-expression networks reveals molecular pathways underlying Alzheimer’s disease and progressive supranuclear palsy 92%
- ACE1 Does Not Influence Cerebral Aβ Degradation or Amyloid Plaque Accumulation in 5XFAD Mice 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.